Prevalence of depression and anxiety during pregnancy versus general population
If pregnant women are at increased risk of depression and anxiety, the prevalence of these disorders should be higher in pregnant women than the general population of women (Van Bussel et al., 2006) . A meta-analysis of 21 studies conducted by Bennett et al. (2004) reported a pooled prevalence for depression of 7.4%, 12.8% and 12.0%, for the first, second and third trimesters of pregnancy, respectively. These estimates, which included depression diagnosed by structured interview and symptom scales, are not dissimilar to the 8.7% rate for 'any prior 12 month affective disorder' reported for women aged 25-34 years in the 2007 Australian National Survey of Mental Health and Wellbeing (NSMHWB) (Australian Bureau of Statistics (ABS), 2008). Gavin et al. (2005) reported that the prevalence of Major Depression alone was 3.8%, 4.9% and 3.1% by pregnancy trimester. These rates are again similar to results from the National Comorbidity Survey (NCS) in the US, which reported 5.0% prevalence of Major Depression for women aged 18-34 years (Kessler et al., 2010) .
A review by Ross and McLean (2006) found rates of prenatal General Anxiety Disorder (GAD) ranged from 4.4-8.5% in four separate studies. More recently, Reck et al. (2008) reported that 2.3% of women experienced GAD between 0 and 3 months post-partum. These rates are not dissimilar to 12-month prevalence rates for GAD in the NSMHWB and the NCS: approximately 5% for women aged 25-34 years (Hunt et al., 2002; Wittchen et al., 1994) .
Comparison studies of pregnant and non-pregnant women
A number of cohort studies have directly compared the prevalence of depression and anxiety between groups of pregnant and non-pregnant women. O'Hara et al. (1990) found no differences in rates of Major and Minor Depression between pregnant women (n=191) and a matched group of non-pregnant women (n=189). However, pregnant women were found to have significantly higher levels of sub-threshold depressive symptomatology. Breitkopf et al. (2006) found no difference in anxiety scores between pregnant and non-pregnant women using the State-Trait Anxiety Inventory (STAI). Recent crosssectional work conducted by Uguz et al. (2010) found comparable rates of mood and anxiety disorders in pregnant women (8.1%; 15.5%) and matched controls (7.5%; 15.0%). Further cross-sectional work using a nationally representative sample in the US reported that pregnant women had a lower risk of mood disorders than non-pregnant women and no difference in the risk of anxiety disorders (Vesga-Lopez et al., 2008) . Taken together, these studies give no clear evidence that pregnancy is associated with more disorders. However, the possibility that subthreshold depression symptoms might be elevated during pregnancy is raised.
Longitudinal, population-based research
Cross-sectional studies that compare prevalence rates between pregnant women and other women are limited in their ability to quantify the effects of pregnancy on mental health. Meta-analyses and systematic reviews (Bennett et al., 2004; Ross and McLean, 2006) report substantial heterogeneity in the rates of depression and anxiety disorders during pregnancy, likely due to differences in study sample characteristics, methodology and measurement. In addition, the majority of studies are cross-sectional, and, thus, have no prospective information about pre-pregnancy symptoms, or change in symptom levels. The reliability of conclusions is also hampered by the use of convenience samples, often recruited from antenatal clinics.
Mental health changes from pre-pregnancy to pregnancy are best tested using longitudinal, population-level data. By assessing the same sample of women both prior to and during pregnancy, and adopting the same measurement methods at each time point, many of the limitations associated with selection and measurement differences are eliminated. Several studies have measured symptoms throughout pregnancy longitudinally, but did not include a parallel comparison non-pregnant control group or pre-pregnancy mental health status from pregnant participants (Bennett et al., 2004; Figueiredo and Conde, 2011; Martini et al., 2013) . Only one identified prospective cohort study has investigated whether psychological distress increases from pre-pregnancy to pregnancy. Van Bussel et al. (2006) used a prospective community-based design to assess women in the United Kingdom prior to, during, and after pregnancy. The authors used a general measure of psychological distress (General Health Questionnaire) and found no significant differences in symptom change between the pregnant and control group over time.
Aim
The current study used three waves of data from a large Australian community sample in which women who later became pregnant were recruited prospectively. We sought to determine whether pregnancy was associated with increases in levels of anxiety and depression, taking into account symptom levels before pregnancy. Depression and anxiety were assessed using a continuous count of symptoms given previous research indicating there may be an increase in subclinical symptom levels (Halbreich, 2004; Lips, 1985; O'Hara et al., 1990) .
Method

Participants and procedure
The Personality and Total Health (PATH) Through Life Project is a prospective narrow-age cohort community survey concerned with health and well-being (Anstey et al., 2012) . The PATH study was approved by the Australian National University's Human Research in Ethics Committee. Three cohorts were recruited from Canberra and Queanbeyan in Australia in 1999 (20-24, 40-44 and 60-64 years) . The sample for this study included women from the youngest cohort. A total of 1241 women aged 20-24 years were recruited from the Canberra and Queanbeyan electoral roll and completed the baseline assessment in 1999 (58.6% recruitment rate). Subsequently, 1126 (91%) and 1058 (85%) women completed the first and second follow-up in 2003 and 2007. Only women who participated in at least waves 1 and 2 were considered. There were no significant differences in levels of depression or anxiety between women who dropped out before wave 3 and those who remained. Over the 8 years of the study, 76 women were pregnant at follow-up (2003 or 2007 interview) . Only primigravidae women were studied, as multiple pregnancies would introduce additional confounding factors.
Study measures
All measures were consistent across the three waves of data collection. Depression and anxiety were measured using the Goldberg Depression and Anxiety Scales (Goldberg et al., 1988) . Both scales consist of nine items representing symptoms of depression/anxiety, each rated with a 'yes/no' response (0-9). The Goldberg scales effectively detect elevated levels of depression and anxiety in community samples (Mackinnon et al., 1994) ; however, to our knowledge they have not been used with a pregnant population. Reflecting the approach taken in the Edinburgh Postnatal Depression Scale (EPDS; Cox et al., 1987) , we excluded four somatic items from each scale to reduce the risk of 'pregnancy-bias' (e.g. 'Have you had headaches/ neck aches?', 'Have you been sleeping poorly?'). The reduced scales ranged from 0 to 5, and demonstrated good reliability within both the pregnant (Cronbach's alpha: depression=0.82, anxiety=0.70) and non-pregnant groups (Cronbach's alpha: depression=0.81, anxiety=0.76). The full Goldberg scales were used in sensitivity analyses. Pregnancy was ascertained by asking the women if they were pregnant, and, if so, how many months. Potential confounders adjusted for included age at baseline, years of education, marital status, employment status, recent financial problems, current contraception use, and current medication use for anxiety and/or depression. These confounders were asked at each wave of data collection, and thus were included in the analyses as time-varying covariates.
Cohorts
The cohort design sought to maximize available data at each wave and to use appropriate groups for comparison (see Christensen et al. (2010) for a similar approach). Figure 1 shows the relevant patterns in pregnancy identified and the subgroups formed. At wave 1, two groups of women were either pregnant (n=20) or already had children (n=151). Because no information was available about the symptom levels of these women pre-pregnancy, they were excluded. A further group were excluded as they became pregnant between waves 1 and 2 (n=76) (thus there was no information on symptom levels at the time they were pregnant). Group 1 (G1, n=30) consisted of women who were pregnant at wave 2. To assess change in anxiety and depression levels across waves 1 and 2, Group 1 was compared with Group 2 (G2, n=700), who remained never pregnant at both time points. Group 3 (G3, n=46) consisted of those who were pregnant at wave 3. To assess change in anxiety and depression levels across waves 2 and 3, Group 3 was compared with Group 4 (G4, n=542) who remained never pregnant at both time points.
Statistical analyses
Independent samples t-tests and chi-squared tests were used to test baseline differences. Mixed model repeated measures (MMRM) analyses of variance (ANOVAs) with pregnancy group and wave as factors assessed differences in the change of levels of anxiety and depression between the relevant subgroups. The covariates were included as time-varying factors to adjust for changes in external correlates over time. Within-participant variation was modelled using an unstructured covariance matrix. The outcomes of conventional tests of each main effect and the interaction were not relevant to this study. Instead, a two degree of freedom contrast was specified to test the two comparisons of interest: (1) change from wave 1 to 2 was compared between those pregnant at wave 2 (G1) and those not pregnant at or before wave 2 (G2) (Comparison 1); and (2) change from wave 2 to wave 3 was compared between those pregnant at wave 3 (G3) and those not pregnant at or before wave 3 (G4) (Comparison 2). Results from each individual comparison were available, enabling exploration of effects present only for wave 2 or for wave 3. The results from each individual comparison were also pooled to provide an aggregate (and more powerful) estimate of overall change.
Sensitivity analyses indicated that, given the size of relevant subgroups, individual contrasts would have 80% power to detect between-group differences in the range 0.3-0.5 standard deviations. Significance was set at p=0.05. Table 1 shows baseline information for each sample group included in each comparison. G1 was older (t(728)=−2.99, p=0.003) and more likely to be married (χ 2 =35.88(1), p<0.001) than G2. G3 was no different on any of the covariates to G4. Additional comparisons between the pregnant G1 and G3, showed G1 was older than G2 (t(74)=−2.78, p=0.007) and more likely to be married (χ 2 =16.37(1), p<0.001). Table 2 shows the mean scores for levels of depression and anxiety at each wave. Most importantly, at wave 1 (baseline) there were no significant differences between any of the groups -for either depression or anxiety levels. At wave 2, G1 had lower anxiety levels than G2 (t(272)=−2.19, p=0.029), but there were no differences between G3 and G4. At wave 3, there were no differences between any of the groups.
Results
The hypothesis testing contrasts within the MMRM ANOVAs found no significant differences in change for depression from waves 1 to 2 (Comparison 1) or waves 2 to 3 (Comparison 2) between those who became pregnant and those who remained non-pregnant (Table 3) . Thus, the aggregate effect of both contrasts combined was not significant (F(2,781)=1. 25, p=0.288) . Changes in anxiety levels were significantly different from waves 1 and 2 between those who became pregnant and those who did not (Comparison 1). Those who became pregnant at wave 2 experienced a greater decrease in anxiety symptoms (from pre-pregnancy) than those who remained non-pregnant (mean difference in change scores=−0.952, p=0.009). While change in anxiety levels between waves 2 and 3 showed a similar trend, the difference was not significant (Comparison 2). However, the aggregate effect of both contrasts combined was significant (F(2,775)=4.16, p=0.016). The estimated marginal mean scores for depression and anxiety symptoms for each sample group across both comparisons can be seen in Figure 2 (adjusted for covariates).
Sensitivity analyses
The MMRM ANOVAs were repeated using the full Goldberg Depression and Anxiety scales to investigate the implications of excluding the somatic items. Again, there were no significant differences in change for depression from waves 1 to 2 between those who became pregnant and those who did not (Comparison 1); however, there were significant differences between waves 2 and 3 (Comparison 2). Those who became pregnant at wave 3 experienced a greater increase in depression scores (from pre-pregnancy) than those who remained non-pregnant (t(680)=2.13, p=0.033). However, the aggregate effect of the two contrasts was not significant (F(2,781)=2.36, p=0.095). When anxiety symptoms were examined, the significant effects from the previous analyses using the restricted scales were no longer present. This was the case both for Comparison 1 assessing change from waves 1 to 2 (t(751)=−1.65, p=0.100) and the aggregate across both comparisons (F(2,764)=1.38, p=0.252).
Discussion
Pregnancy was not found to be associated with increases in depression or anxiety. There was no association between becoming pregnant and change in depression. Pregnant women experienced a greater decline in anxiety from prepregnancy levels than those who remained non-pregnant. Importantly, these effects are unlikely to be the result of pre-existing differences in psychological distress, or simply an artefact involving regression to the mean, as the groups did not differ in levels of depression or anxiety pre-pregnancy. Including somatic items resulted in greater anxiety and depression for women whilst pregnant, indicating possible item bias. While much of the previous literature has been discordant, the current findings are consistent with the only other prospective cohort study with pre-pregnancy data available. This study also found no change in psychological distress during pregnancy (Van Bussel et al., 2006) using the General Health Questionnaire as an outcome measure (which does not contain items assessing somatic symptoms). We know of no other study reporting a decrease of anxiety symptoms from pre-pregnancy to pregnancy. We expected that pregnancy might lead to small but significant sub-threshold symptom increases in depression, but this was not the case. This contrasts with O'Hara et al. (1990) and Halbreich (2004) , who suggest pregnancy may be associated with higher levels of symptomatology but not diagnosed disorders. However, a closer examination of O'Hara et al.'s study shows that pregnant women only reported increased depression when depression was measured using both the Cognitive-Affective and the Somatic subscales of the Beck Depression Inventory. Consistent with the current study's findings, there were no significant differences between pregnant and non-pregnant groups on the Cognitive-Affective subscale alone.
Measurement implications
The current study clearly demonstrates that the assessment tool used to measure depression and anxiety during pregnancy influences the estimates obtained. Our findings indicate that measures that include somatic items yield higher estimates of morbidity amongst pregnant women than measures which exclude these items. While the current study did not conduct a formal analysis of item bias with regard to pregnancy status, the findings concord with previous research suggesting somatic items can be 'pregnancybiased' (Matthey, 2010; O'Hara et al., 1990) . While the concern around 'perinatal-biased' measures is not new, and was the impetus for the development of the EPDS (Cox et al., 1987; Pop et al., 1992) (Matthey, 2010) .
Limitations
Several limitations to the current study need to be noted. Variation in anxiety across specific time-points within pregnancy (e.g. by trimester) could not be confidently assessed due to the sample size available. Related to this point, data for individuals in the PATH study were collected every 4 years. Although several time-varying variables were adjusted for, other (unmeasured) life circumstances impacting on mental health may have intervened in the interim between collecting baseline data and follow-up pregnancy. The experience of pregnancy was not assessed beyond the age of 32 years, as the PATH cohort was aged 24-28 at wave 2 and 28-32 at wave 3. While this age-range is likely to have captured many women's first births (the median age of first-time mothers in Australia was 29.1 years in 2012 (ABS, 2012)), it may be that women older than 32 have a different experience of their first pregnancy. Diagnostic measures of mental health (i.e. mental disorders) and measures specifically designed for the perinatal period were not available. However, the primary concern with general measures is the inclusion of items measuring somatic symptoms; the potential impact of these items was assessed in the current study. The current study's ability to detect change was potentially limited because of the size of the pregnant groups (aggregate n=76). As such, steps were taken to maximize power and minimize false-negative findings, including no adjustment for multiple testing and aggregate testing of contrasts. Small effects were found to be significant at the 0.05 level adopted, as predicted in preliminary power analyses. The small sample size also limits generalizability of the findings (as discussed further below), and highlights the need for future follow-up research.
It is important to note the population used in the current study, and how that might impact the findings. The sample was taken from Canberra (ACT) and Queanbeyan (NSW) in Australia. This location has been shown to be more affluent with lower unemployment rates than other states and territories in Australia (ABS, 2014), suggesting the findings may not be representative of the broader Australian population. However, in defence of the population used, findings from the beyondblue National Postnatal Depression Program did not find lower rates of post-natal depression in the ACT (EPDS >9: 16%; EPDS >12: 7.1%) as opposed to Australian rates (EPDS >9: 15.5%; EPDS >12: 7.5%) (Buist et al., 2008) . In any case, further research replicating the current findings is needed. Ideally, this research should include representatives from sub-populations where psychological problems may be most prevalent, such as non-Caucasian, unmarried, those with marital problems and teenage individuals (Bilszta et al., 2008; Halbreich, 2004; Quinlivan et al., 2004; Rich-Edwards et al., 2006) . Data on other potential risk factors should also be included, such as women's pregnancy circumstances (e.g. unwanted/unintended pregnancy) (Dingle et al., 2008; Fergusson et al., 2008) . While the aim of the current study was to take a broad population-based approach to consider whether women in the community 'generally' experience increases in anxiety and depression during pregnancy, further research is needed to tease out how the current findings might differ for different types of women and build on the body of 'risk factor' research available.
While there are limitations to the current study, it is important to also recognize its methodological advances. The availability of longitudinal data and the use of longitudinal analysis techniques, together with information on prepregnancy symptomology is unique, and provides a framework for future studies to advance upon.
Conclusions
This study is one of the first to follow a community sample of women from pre-pregnancy, and assess the impact of pregnancy on levels of depression and anxiety. The results show no increase in depression or anxiety symptoms during pregnancy. To date, the rhetoric has largely focused on the negative psychological symptoms associated with pregnancy. This is understandable, given the adverse impacts of pre-and post-natal depressive and anxiety disorders for women themselves, their partners and children. While the current study suggests that the average pregnant women is not at increased risk, it is important to remember that some pregnant women will be at greater risk, and future risk-factor research should continue to examine how we can best identify and offer treatment. Discussion should continue regarding whether routine and universal screening, as recommended by the National Perinatal Depression Initiative, is the most effective way to identify women most at risk.
